Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Celldex Therapeutics - 30 Year Stock Price History | CLDX

Historical daily share price chart and data for Celldex Therapeutics since 1990 adjusted for splits. The latest closing stock price for Celldex Therapeutics as of February 21, 2020 is 3.07.
  • The all-time high Celldex Therapeutics stock closing price was 3014.70 on March 06, 2000.
  • The Celldex Therapeutics 52-week high stock price is 6.21, which is 102.3% above the current share price.
  • The Celldex Therapeutics 52-week low stock price is 2.01, which is 34.5% below the current share price.
  • The average Celldex Therapeutics stock price for the last 52 weeks is 2.87.
  
Celldex Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 2.3896 2.2500 3.0700 2.2300 3.0700 37.67%
2019 3.2988 3.7571 10.3553 2.0500 2.2300 -24.84%
2018 15.8068 43.7781 46.0270 2.9235 2.9670 -93.03%
2017 44.1016 54.1229 59.3703 33.5832 42.5787 -19.77%
2016 73.3586 224.7376 231.9340 43.0285 53.0735 -77.42%
2015 312.9721 276.0120 476.4618 155.6222 235.0825 -14.08%
2014 267.4752 368.9655 473.6132 166.2669 273.6132 -24.62%
2013 266.9407 104.9475 567.1664 104.6477 362.9685 260.80%
2012 75.1824 41.6792 103.8981 41.5292 100.5997 158.08%
2011 49.8028 63.2684 66.8666 31.6342 38.9805 -36.89%
2010 76.6517 70.6147 141.3793 51.2744 61.7691 -11.78%
2009 101.9175 119.7901 172.4138 62.9685 70.0150 -41.04%
2008 155.2623 100.7899 269.5652 67.9160 118.7406 31.95%
2007 161.1736 246.5754 278.9722 73.7926 89.9910 -62.69%
2006 299.2865 338.3662 457.1544 228.5772 241.1759 -28.72%
2005 271.9586 368.9632 390.5610 208.7792 338.3662 -6.47%
2004 420.2081 496.7504 678.5323 282.5718 361.7639 -26.64%
2003 357.5000 210.5790 554.3447 174.5826 493.1508 142.48%
2002 271.4872 707.3294 721.7280 129.5871 203.3797 -71.82%
2001 845.8938 1159.0843 1519.0484 404.9596 721.7280 -41.63%
2000 1471.3889 415.7585 3014.6991 370.7630 1236.4766 178.14%
1999 331.9312 349.1652 561.5440 201.5799 444.5556 41.14%
1998 391.2824 404.9596 809.9192 190.7810 314.9686 -28.28%
1997 333.6141 291.5709 568.7432 230.3770 439.1562 50.62%
1996 484.5131 584.9416 786.5215 286.1714 291.5709 -48.08%
1995 650.5994 449.9551 966.5035 426.5574 561.5440 24.80%
1994 721.9137 1529.8473 1529.8473 381.5619 449.9551 -67.74%
1993 1211.2862 1304.8698 1461.4541 854.9147 1394.8608 5.16%
1992 1461.5179 2226.3778 2519.7485 1056.4946 1326.4676 -33.00%
1991 1256.0470 516.5484 2474.7530 516.5484 1979.8024 274.15%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.037B $0.010B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $131.020B 14.98
CSL (CSLLY) Australia $101.716B 0.00
Gilead Sciences (GILD) United States $84.765B 10.91
Vertex Pharmaceuticals (VRTX) United States $63.547B 57.67
Biogen (BIIB) United States $58.597B 10.01
Illumina (ILMN) United States $44.168B 45.66
Regeneron Pharmaceuticals (REGN) United States $43.913B 18.60
Alexion Pharmaceuticals (ALXN) United States $22.702B 10.56
Seattle Genetics (SGEN) United States $20.383B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.260B 0.00
Incyte (INCY) United States $17.943B 38.50
BioMarin Pharmaceutical (BMRN) United States $16.105B 0.00
Genmab (GNMSF) Denmark $15.176B 48.81
Alnylam Pharmaceuticals (ALNY) United States $14.987B 0.00
Galapagos (GLPG) Belgium $14.255B 36.73
Exact Sciences (EXAS) United States $13.326B 0.00
Bio-Rad Laboratories (BIO.B) United States $12.088B 56.48
BeiGene (BGNE) Cayman Islands $10.443B 0.00
Sarepta Therapeutics (SRPT) United States $9.176B 0.00
QIAGEN (QGEN) Netherlands $8.414B 25.91
Guardant Health (GH) United States $8.209B 0.00
Bio-Techne Corp (TECH) United States $8.011B 54.82
BioNTech SE (BNTX) Germany $7.326B 0.00
Ascendis Pharma (ASND) Denmark $6.928B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.905B 0.00
Reata Pharmaceuticals (RETA) United States $6.773B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.750B 17.16
Exelixis (EXEL) United States $6.527B 18.36
Amarin (AMRN) Ireland $6.383B 0.00
Moderna (MRNA) United States $6.239B 0.00
ARGENX SE-ADR (ARGX) Netherlands $6.142B 0.00
Repligen (RGEN) United States $5.264B 96.31
Acceleron Pharma (XLRN) United States $5.035B 0.00
China Biologic Products (CBPO) China $4.598B 25.90
Bluebird Bio (BLUE) United States $4.584B 0.00
Adaptive Biotechnologies (ADPT) United States $4.203B 0.00
MorphoSys AG (MOR) Germany $3.896B 0.00
Mirati Therapeutics (MRTX) United States $3.706B 0.00
Blueprint Medicines (BPMC) United States $3.672B 0.00
Zai Lab (ZLAB) China $3.650B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.523B 0.00
Immunomedics (IMMU) United States $3.486B 0.00
NeoGenomics (NEO) United States $3.456B 183.89
CRISPR Therapeutics AG (CRSP) Switzerland $3.454B 58.51
Momenta Pharmaceuticals (MNTA) United States $3.363B 0.00
Emergent Biosolutions (EBS) United States $3.334B 23.31
Alkermes (ALKS) Ireland $3.224B 255.38
Genmab (GMAB) Denmark $3.220B 12.63
Halozyme Therapeutics (HALO) United States $3.149B 0.00
MyoKardia (MYOK) United States $3.142B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.074B 0.00
UniQure (QURE) Netherlands $2.774B 0.00
Amicus Therapeutics (FOLD) United States $2.760B 0.00
Insmed (INSM) United States $2.719B 0.00
Arena Pharmaceuticals (ARNA) United States $2.667B 6.20
Denali Therapeutics (DNLI) United States $2.379B 0.00
Epizyme (EPZM) United States $2.321B 0.00
Principia Biopharma (PRNB) United States $2.290B 0.00
Fate Therapeutics (FATE) United States $2.219B 0.00
RA PHARMCTL INC (RARX) United States $2.205B 0.00
Alector (ALEC) United States $2.059B 0.00
REGENXBIO (RGNX) United States $1.977B 0.00
Zymeworks (ZYME) Canada $1.829B 0.00
Ligand Pharmaceuticals (LGND) United States $1.780B 51.97
Akcea Therapeutics (AKCA) United States $1.732B 0.00
Arvinas (ARVN) United States $1.711B 0.00
Coherus BioSciences (CHRS) United States $1.578B 0.00
Myriad Genetics (MYGN) United States $1.483B 26.17
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Zealand Pharma (ZEAL) Denmark $1.474B 0.00
Zealand Pharma (ZLDPF) Denmark $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.404B 0.00
Intra-Cellular Therapies (ITCI) United States $1.361B 0.00
Editas Medicine (EDIT) United States $1.349B 0.00
Revance Therapeutics (RVNC) United States $1.244B 0.00
Athenex (ATNX) United States $1.193B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.189B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.187B 0.00
Twist Bioscience (TWST) United States $1.174B 0.00
PHARMA MAR SA (PHMMF) Spain $1.029B 0.00
Adverum Biotechnologies (ADVM) United States $1.017B 0.00
Mesoblast (MESO) Australia $0.931B 0.00
Cytokineticsorporated (CYTK) United States $0.915B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Sangamo Therapeutics (SGMO) United States $0.874B 0.00
DBV Technologies S.A (DBVT) France $0.874B 0.00
Vericel (VCEL) United States $0.851B 317.17
Codexis (CDXS) United States $0.823B 0.00
Heska (HSKA) United States $0.805B 205.60
Cellectis S.A (CLLS) France $0.797B 0.00
Intrexon (PGEN) United States $0.768B 0.00
Retrophin (RTRX) United States $0.738B 0.00
ANI Pharmaceuticals (ANIP) United States $0.736B 12.56
Arcus Biosciences (RCUS) United States $0.731B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.716B 6.02
Cara Therapeutics (CARA) United States $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.688B 0.00
GENFIT S.A (GNFT) France $0.677B 0.00
Kadmon Holdings (KDMN) United States $0.655B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.640B 0.00
UROGEN PHARMA (URGN) United States $0.632B 0.00
Cel-Sci (CVM) United States $0.620B 0.00
Bellus Health (BLU) Canada $0.601B 0.00
Anika Therapeutics (ANIK) United States $0.599B 20.49
Clovis Oncology (CLVS) United States $0.591B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.590B 0.00
NantKwest (NK) United States $0.586B 0.00
AC Immune SA (ACIU) Switzerland $0.568B 13.13
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.552B 0.00
Puma Biotechnology (PBYI) United States $0.544B 0.00
Compugen (CGEN) Israel $0.539B 0.00
Agenus (AGEN) United States $0.521B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.515B 0.00
Prothena (PRTA) Ireland $0.477B 0.00
Cue Biopharma (CUE) United States $0.477B 0.00
BioDelivery Sciences (BDSI) United States $0.473B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Merus (MRUS) Netherlands $0.449B 0.00
Sorrento Therapeutics (SRNE) United States $0.445B 0.00
Mersana Therapeutics (MRSN) United States $0.444B 0.00
AnaptysBio (ANAB) United States $0.435B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.432B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.423B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.414B 0.00
Dynavax Technologies (DVAX) United States $0.412B 0.00
Precision BioSciences (DTIL) United States $0.409B 0.00
Avid Bioservices (CDMO) United States $0.407B 0.00
Pfenex (PFNX) United States $0.407B 0.00
PDL BioPharma (PDLI) United States $0.396B 9.91
Gritstone Oncology (GRTS) United States $0.372B 0.00
Kindred Biosciences (KIN) United States $0.369B 0.00
Inovio Pharmaceuticals (INO) United States $0.369B 0.00
Stemline Therapeutics (STML) United States $0.356B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 0.00
WAVE Life Sciences (WVE) Singapore $0.333B 0.00
Albireo Pharma (ALBO) United States $0.325B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.319B 0.00
OSMOTICA PHARM (OSMT) United States $0.313B 0.00
MannKind (MNKD) United States $0.312B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Syros Pharmaceuticals (SYRS) United States $0.311B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.303B 2.10
Starpharma Holdings (SPHRY) Australia $0.302B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.297B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.276B 0.00
Kamada (KMDA) Israel $0.274B 11.39
POXEL SA FRANCE (PXXLF) France $0.271B 0.00
VBI Vaccines (VBIV) United States $0.267B 0.00
Seres Therapeutics (MCRB) United States $0.267B 0.00
IVERIC Bio (ISEE) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.264B 0.00
Geron (GERN) United States $0.256B 0.00
Novavax (NVAX) United States $0.255B 0.00
Biofrontera AG (BFRA) Germany $0.253B 0.00
XOMA (XOMA) United States $0.251B 0.00
Protagonist Therapeutics (PTGX) United States $0.251B 0.00
ChromaDex (CDXC) United States $0.243B 0.00
Kala Pharmaceuticals (KALA) United States $0.240B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.234B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Prometic Life Sciences (LMNL) Canada $0.228B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.225B 0.00
Alcobra (ARCT) United States $0.223B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.223B 11.46
Pieris Pharmaceuticals (PIRS) United States $0.216B 0.00
Arbutus Biopharma (ABUS) Canada $0.212B 0.00
Cerecor (CERC) United States $0.211B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.211B 0.00
Affimed (AFMD) Germany $0.209B 0.00
Theratechnologies (THTX) Canada $0.209B 0.00
Abeona Therapeutics (ABEO) United States $0.206B 0.00
VolitionRX (VNRX) Singapore $0.205B 0.00
TELA Bio (TELA) United States $0.200B 0.00
Athersys (ATHX) United States $0.199B 0.00
Five Prime Therapeutics (FPRX) United States $0.195B 0.00
Fortress Biotech (FBIO) United States $0.195B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 4.99
Spero Therapeutics (SPRO) United States $0.184B 0.00
Exicure (XCUR) United States $0.183B 0.00
Windtree Therapeutics (WINT) United States $0.168B 0.00
Northwest Biotherapeutics (NWBO) United States $0.166B 0.00
CorMedix Inc (CRMD) United States $0.166B 0.00
Selecta Biosciences (SELB) United States $0.161B 0.00
Aptinyx (APTX) United States $0.160B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Verastem (VSTM) United States $0.156B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Liquidia Technologies (LQDA) United States $0.147B 0.00
Celyad SA (CYAD) Belgium $0.145B 0.00
ARAVIVE, INC (ARAV) United States $0.143B 0.00
Palatin Technologies (PTN) United States $0.141B 3.85
Antibe Therapeutics (ATBPF) Canada $0.141B 0.00
PHASEBIO PHARMA (PHAS) United States $0.139B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Menlo Therapeutics (MNLO) United States $0.128B 0.00
OvaScience (MLND) United States $0.123B 0.00
Clearside Biomedical (CLSD) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.120B 0.00
Enzo Biochem (ENZ) United States $0.105B 0.00
Prima BioMed (IMMP) Australia $0.105B 0.00
Applied Genetic Technologies (AGTC) United States $0.104B 0.00
Proteostasis Therapeutics (PTI) United States $0.101B 0.00
Happiness Biotech Group (HAPP) China $0.100B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.094B 0.00
Emmaus Life Sciences (EMMA) United States $0.093B 0.00
Vaccinex (VCNX) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Synlogic (SYBX) United States $0.089B 0.00
Checkpoint Therapeutics (CKPT) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.084B 0.00
AIT Therapeutics (XAIR) United States $0.083B 0.00
Catalyst Biosciences (CBIO) United States $0.082B 0.00
Pluristem Therapeutics (PSTI) Israel $0.079B 0.00
Orgenesis (ORGS) United States $0.078B 5.05
Acorda Therapeutics (ACOR) United States $0.075B 0.00
Trevena (TRVN) United States $0.071B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.071B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Soligenix (SNGX) United States $0.069B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.067B 0.00
DiaMedica Therapeutics (DMAC) United States $0.067B 0.00
Advaxis (ADXS) United States $0.061B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Protalix BioTherapeutics (PLX) Israel $0.057B 0.00
China Health Industries Holdings (CHHE) China $0.056B 16.98
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Idera Pharmaceuticals (IDRA) United States $0.048B 0.00
Curis (CRIS) United States $0.047B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.046B 0.00
AmpliPhi Biosciences (ARMP) United States $0.044B 0.00
Evogene (EVGN) Israel $0.040B 0.00
AquaBounty Technologies (AQB) United States $0.037B 0.00
Entera Bio (ENTX) Israel $0.036B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Alimera Sciences (ALIM) United States $0.033B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
Celsion (CLSN) United States $0.031B 0.00
BioCardia (BCDA) United States $0.030B 0.00
Signal Genetics (MGEN) United States $0.029B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.028B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.028B 0.00
IBio (IBIO) United States $0.026B 0.00
VIVUS (VVUS) United States $0.026B 0.00
Novogen (KZIA) Australia $0.025B 0.00
Unum Therapeutics (UMRX) United States $0.024B 0.00
Aptevo Therapeutics (APVO) United States $0.022B 0.00
Cleveland BioLabs (CBLI) United States $0.022B 0.00
TOCAGEN INC (TOCA) United States $0.022B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Genetic Technologies (GENE) Australia $0.016B 0.00
Titan Pharmaceuticals (TTNP) United States $0.016B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.016B 0.00
Aytu Bioscience (AYTU) United States $0.015B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.005B 0.00
Neuralstem (SNCA) United States $0.004B 0.00